[
  {"call_id":"NOVO-CALL-2026-A","sponsor_company":"Novo Nordisk","drug":"semaglutide","call_type":"open IIT","deadline":"2026-05-18","eligibility":"Faculty PI, IRB approved, Korea/Asia priority"},
  {"call_id":"NOVO-CALL-2026-B","sponsor_company":"Novo Nordisk","drug":"cagrilintide+semaglutide","call_type":"open IIT","deadline":"2026-06-08","eligibility":"Phase 2 ready, CGM, DXA, IRB"},
  {"call_id":"NOVO-CALL-2026-C","sponsor_company":"Novo Nordisk","drug":"amycretin","call_type":"exploratory","deadline":"2026-07-20","eligibility":"prior GLP-1 experience required"},
  {"call_id":"LILLY-CALL-2026-A","sponsor_company":"Lilly","drug":"tirzepatide","call_type":"open IIT","deadline":"2026-05-29","eligibility":"MASLD or T2DM, biopsy/MRI capable site"},
  {"call_id":"LILLY-CALL-2026-B","sponsor_company":"Lilly","drug":"retatrutide","call_type":"exploratory","deadline":"2026-07-10","eligibility":"senior PI, multi-modal phenotyping site"},
  {"call_id":"LILLY-CALL-2026-C","sponsor_company":"Lilly","drug":"orforglipron","call_type":"post-market RWE","deadline":"2026-08-16","eligibility":"prior tirzepatide/semaglutide experience"},
  {"call_id":"MADRIGAL-CALL-2026-A","sponsor_company":"Madrigal","drug":"resmetirom","call_type":"RWE IIT","deadline":"2026-05-23","eligibility":"prior resmetirom experience, biopsy/MRI"},
  {"call_id":"MADRIGAL-CALL-2026-B","sponsor_company":"Madrigal","drug":"resmetirom","call_type":"biomarker","deadline":"2026-06-22","eligibility":"MASH biopsy site"},
  {"call_id":"MADRIGAL-CALL-2026-C","sponsor_company":"Madrigal","drug":"resmetirom","call_type":"Korean RWE","deadline":"2026-09-01","eligibility":"Korean site, biopsy/MRI"},
  {"call_id":"BAYER-CALL-2026-A","sponsor_company":"Bayer","drug":"finerenone","call_type":"obesity-CKD IIT","deadline":"2026-06-18","eligibility":"prior finerenone, CT-experience"},
  {"call_id":"BAYER-CALL-2026-B","sponsor_company":"Bayer","drug":"ASGR1 antagonist","call_type":"NASH exploratory","deadline":"2026-08-08","eligibility":"NASH biopsy/MRI"},
  {"call_id":"BAYER-CALL-2026-C","sponsor_company":"Bayer","drug":"finerenone","call_type":"Korean obesity-CKD","deadline":"2026-07-26","eligibility":"senior PI, Korean site"},
  {"call_id":"PFIZER-CALL-2026-A","sponsor_company":"Pfizer","drug":"danuglipron","call_type":"oral GLP-1 IIT","deadline":"2026-07-12","eligibility":"prior GLP-1 experience"},
  {"call_id":"PFIZER-CALL-2026-B","sponsor_company":"Pfizer","drug":"NASH compound","call_type":"NASH exploratory","deadline":"2026-09-12","eligibility":"NASH biopsy/MRI"},
  {"call_id":"AKERO-CALL-2026-A","sponsor_company":"Akero","drug":"efruxifermin","call_type":"NASH IIT","deadline":"2026-08-10","eligibility":"NASH biopsy site"}
]